These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 8850231)
1. [Quantitative evaluation of juxtatrabecular fibrosis in myelodysplastic syndromes]. Reissenweber N; Gualco G; Panuncio A; Díaz G Sangre (Barc); 1995 Dec; 40(6):479-83. PubMed ID: 8850231 [TBL] [Abstract][Full Text] [Related]
2. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases. Orazi A Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881 [TBL] [Abstract][Full Text] [Related]
3. Physician Education: Myelodysplastic Syndrome. Yoshida Y Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004 [TBL] [Abstract][Full Text] [Related]
4. Myelofibrosis in primary myelodysplastic syndromes: a retrospective study of 352 patients. Maschek H; Georgii A; Kaloutsi V; Werner M; Bandecar K; Kressel MG; Choritz H; Freund M; Hufnagl D Eur J Haematol; 1992 Apr; 48(4):208-14. PubMed ID: 1592101 [TBL] [Abstract][Full Text] [Related]
5. Percentages of bone marrow blasts and chromosomal changes in patients with refractory anemia help to determine prognoses. Iwabuchi A; Ohyashiki K; Ohyashiki JH; Kimura Y; Lin KY; Aizawa S; Nehashi Y; Miyazawa K; Yaguchi M; Toyama K Int J Hematol; 1994 Oct; 60(3):207-13. PubMed ID: 7858240 [TBL] [Abstract][Full Text] [Related]
6. Presence of peripheral blasts in refractory anemia and refractory cytopenia with multilineage dysplasia predicts an unfavourable outcome. Knipp S; Strupp C; Gattermann N; Hildebrandt B; Schapira M; Giagounidis A; Aul C; Haas R; Germing U Leuk Res; 2008 Jan; 32(1):33-7. PubMed ID: 17412418 [TBL] [Abstract][Full Text] [Related]
7. Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications. Lorand-Metze I; Pinheiro MP; Ribeiro E; de Paula EV; Metze K Leuk Res; 2004 Jun; 28(6):587-94. PubMed ID: 15120935 [TBL] [Abstract][Full Text] [Related]
8. A cytochemical note on nucleoli of granulocytic precursors and granulocytes in patients suffering from the refractory anemia with excess blasts (RAEB) of the myelodysplastic syndrome (MDS). Smetana K; Jirásková I; Malasková V; Cermák J Neoplasma; 2002; 49(1):5-9. PubMed ID: 12044061 [TBL] [Abstract][Full Text] [Related]
10. Accelerated cellular senescence in myelodysplastic syndrome. Wang YY; Cen JN; He J; Shen HJ; Liu DD; Yao L; Qi XF; Chen ZX Exp Hematol; 2009 Nov; 37(11):1310-7. PubMed ID: 19748549 [TBL] [Abstract][Full Text] [Related]
11. A specific cutaneous lesion revealing myelodysplastic syndrome. Kajisawa C; Matsui C; Morohashi M Eur J Dermatol; 1998; 8(7):517-8. PubMed ID: 9854168 [TBL] [Abstract][Full Text] [Related]
12. [Monocytosis and myelomonocytic dysplasia in myelodysplastic syndrome]. Neuwirtová R; Malasková V; Steruská M; Indrák K; Vozobulová V; Haber J; Smolíková A; Musilová J; Jelínek J Vnitr Lek; 1990 Aug; 36(8):738-45. PubMed ID: 2136457 [TBL] [Abstract][Full Text] [Related]
13. The presence of clonal cell subpopulations in peripheral blood and bone marrow of patients with refractory cytopenia with multilineage dysplasia but not in patients with refractory anemia may reflect a multistep pathogenesis of myelodysplasia. Cermák J; Belicková M; Krejcová H; Michalová K; Zilovcová S; Zemanová Z; Brezinová J; Sieglová Z Leuk Res; 2005 Apr; 29(4):371-9. PubMed ID: 15725470 [TBL] [Abstract][Full Text] [Related]
14. Myelofibrosis in primary myelodysplastic syndromes: clinical and biological significance. Marisavljević D; Rolović Z; Cemerikić V; Bosković D; Colović M Med Oncol; 2004; 21(4):325-31. PubMed ID: 15579916 [TBL] [Abstract][Full Text] [Related]
15. Significant correlation between the degree of WT1 expression and the International Prognostic Scoring System Score in patients with myelodysplastic syndromes. Cilloni D; Gottardi E; Messa F; Fava M; Scaravaglio P; Bertini M; Girotto M; Marinone C; Ferrero D; Gallamini A; Levis A; Saglio G; J Clin Oncol; 2003 May; 21(10):1988-95. PubMed ID: 12743153 [TBL] [Abstract][Full Text] [Related]
16. Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndromes. Della Porta MG; Malcovati L; Boveri E; Travaglino E; Pietra D; Pascutto C; Passamonti F; Invernizzi R; Castello A; Magrini U; Lazzarino M; Cazzola M J Clin Oncol; 2009 Feb; 27(5):754-62. PubMed ID: 19103730 [TBL] [Abstract][Full Text] [Related]
17. Acute panmyelosis with myelofibrosis: a clinicopathological study on 46 patients including histochemistry of bone marrow biopsies and follow-up. Thiele J; Kvasnicka HM; Zerhusen G; Vardiman J; Diehl V; Luebbert M; Schmitt-Graeff A Ann Hematol; 2004 Aug; 83(8):513-21. PubMed ID: 15173958 [TBL] [Abstract][Full Text] [Related]
20. Nucleoli in cells of the granulopoietic proliferating compartment in patients suffering from the refractory anemia of the myelodysplastic syndrome. Smetana K; Jirásková ; Cermák J Neoplasma; 2000; 47(5):280-2. PubMed ID: 11130243 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]